LGALS13 Antikörper (AA 30-139)
Kurzübersicht für LGALS13 Antikörper (AA 30-139) (ABIN7268198)
Target
Alle LGALS13 Antikörper anzeigenReaktivität
Wirt
Klonalität
Konjugat
Applikation
-
-
Bindungsspezifität
- AA 30-139
-
Verwendungszweck
- LGALS13 Rabbit pAb
-
Sequenz
- FINDPQLQVD FYTDMDEDSD IAFRFRVHFG NHVVMNRREF GIWMLEETTD YVPFEDGKQF ELCIYVHYNE YEIKVNGIRI YGFVHRIPPS FVKMVQVSRD ISLTSVCVCN
-
Kreuzreaktivität
- Human, Maus, Ratte
-
Produktmerkmale
- Polyclonal Antibodies
-
Aufreinigung
- Affinity purification
-
Immunogen
- Recombinant fusion protein containing a sequence corresponding to amino acids 30-139 of human LGALS13 (NP_037400.1).
-
Isotyp
- IgG
-
-
-
-
Applikationshinweise
- WB,1:500 - 1:2000
-
Beschränkungen
- Nur für Forschungszwecke einsetzbar
-
-
-
Format
- Liquid
-
Buffer
- PBS with 0.02 % sodium azide,50 % glycerol, pH 7.3.
-
Konservierungsmittel
- Sodium azide
-
Vorsichtsmaßnahmen
- This product contains Sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.
-
Lagerung
- -20 °C
-
Informationen zur Lagerung
- Store at -20°C. Avoid freeze / thaw cycles.
-
-
- LGALS13 (Lectin, Galactoside-Binding, Soluble, 13 (LGALS13))
-
Andere Bezeichnung
- LGALS13
-
Hintergrund
- Lysophospholipases are enzymes that act on biological membranes to regulate the multifunctional lysophospholipids. The protein encoded by this gene has lysophospholipase activity. It is composed of two identical subunits which are held together by disulfide bonds. This protein has structural similarity to several members of the beta-galactoside-binding S-type lectin family. [provided by RefSeq, Jul 2008],GAL13,PLAC8,PP13,LGALS13,Cancer,Signal Transduction,Endocrine & Metabolism,Lipid Metabolism,Cardiovascular,Blood,Serum Proteins,LGALS13
-
Molekulargewicht
- 16kDa
-
Gen-ID
- 29124
-
UniProt
- Q9UHV8
Target
-